APA (7th ed.) Citation

Ma, D., Li, S., Cui, Y., Li, L., Liu, H., Chen, Y., & Zhou, X. (2021). Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway. Oncology Letters, 21(3), N.PAG. https://doi.org/10.3892/ol.2021.12480

Chicago Style (17th ed.) Citation

Ma, Dongjie, Shanqing Li, Yushang Cui, Li Li, Hongsheng Liu, Yeye Chen, and Xiaoyun Zhou. "Paclitaxel Increases the Sensitivity of Lung Cancer Cells to Lobaplatin via PI3K/Akt Pathway." Oncology Letters 21, no. 3 (2021): N.PAG. https://doi.org/10.3892/ol.2021.12480.

MLA (9th ed.) Citation

Ma, Dongjie, et al. "Paclitaxel Increases the Sensitivity of Lung Cancer Cells to Lobaplatin via PI3K/Akt Pathway." Oncology Letters, vol. 21, no. 3, 2021, p. N.PAG, https://doi.org/10.3892/ol.2021.12480.